| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Caris Life Sciences, Inc.
13G
CAI · 142152107
|
44.1% |
8/13/2025
Event 6/30/2025
|
||||
| David D. Halbert | 44.1% | |||||
| Caris Halbert, L.P. | 36.0% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.